GlassScriptPhysician profile
Alfonso G Ballesteros
NPI 1497957815
$35,486.21
in general payments reported to CMS, 2019-2025
9 companies · $5,443 in 2025
The $5,443 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $113 · 2021: $9,268 · 2022: $11K · 2023: $5,691 · 2024: $3,573 · 2025: $5,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,518 · Food and Beverage: $2,839 · Travel and Lodging: $2,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,518.10 |
| Food and Beverage | $2,838.73 |
| Travel and Lodging | $2,349.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $33,249.00 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $1,840.90 | 2020-2025 | Phasix Mesh |
| Ethicon US, LLC | $236.99 | 2020-2024 | Ultra Vac, Evarrest, Echelon Flex |
| Solventum Corporation | $48.69 | 2025 | Prevena, V.A.C.Instill |
| Boston Scientific Corporation | $31.26 | 2025 | Spyglass Discover |
| Conmed Corporation | $26.35 | 2024 | Conmed Specimen Retrieval, Airseal |
| Becton, Dickinson and Company | $22.18 | 2025 | Phasix Mesh |
| Kci USA, INC. | $16.65 | 2022 | |
| Smith+Nephew, INC. | $14.19 | 2025 | Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfonso Ballesteros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.